Alkem Laboratories Ltd.

is a leading Indian pharma company with strong domestic branded formulations and a growing US generics business. ​ Chronic and acute therapies, especially anti‑infectives, drive domestic leadership. ​ US business adds diversification but also brings price‑erosion risk. ​ Input cost inflation and regulatory inspections remain key watchpoints